ESSA PHARMA INC (EPIX)
CA29668H7085 - Common Stock
| 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | 2020 (2020-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -28.54M | -26.58M | -35.10M | -36.81M | -23.45M | |||
| Depreciation Amortization | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | -418.81K | 2.34M | -780.00K | 1.95M | -1.24M | |||
| Interest Paid | N/A | N/A | N/A | 0.00 | 30.00K | |||
| Other non cash items | 6.25M | 4.46M | 7.18M | 9.44M | 7.70M | |||
| OPERATING CASH FLOW | -22.72M | -19.78M | -28.70M | -25.42M | -16.98M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| Other Investing Activity | 91.79M | -3.53M | -52.35M | -35.01M | -21.74M | |||
| INVESTING CASH FLOW | 91.79M | -3.53M | -52.35M | -35.01M | -21.74M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | -3.89M | |||
| Stock Issued/Repurchased | 880.00K | 0.00 | 320.00K | 151.19M | 49.25M | |||
| Other Financing Activity | 45.51K | -68.16K | -70.00K | -9.20M | -3.58M | |||
| FINANCING CASH FLOW | 925.51K | -68.16K | 250.00K | 141.99M | 41.78M | |||
| Exchange Rate Effect | 9.10K | 2.46K | 50.00K | -60.00K | -60.00K | |||
| CHANGE IN CASH | 70.01M | -23.37M | -80.75M | 81.50M | 3.00M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -22.72M | -19.78M | -28.70M | -25.42M | -16.98M | |||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| FREE CASH FLOW | -22.72M | -19.78M | -28.70M | -25.42M | -16.98M | |||
All data in USD